HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Thursday, 14 December 2017

An analysis of HTA and reimbursement procedures in EUnetHTA partner countries

A very handy reference document.  A brief summary of findings, taken from the website, is below:
“Data were received from 59 agencies in 31 EUnetHTA partner countries. Data included national procedures as well as regional procedures in Spain and Italy. Twenty-one agencies in 9 countries took part in case studies. 29 out of 31 of countries (94%) reported having procedures for the assessment of pharmaceuticals and 22 out of 31 countries (71%) reported having procedures for the assessment of non-pharmaceutical health technologies. A smaller number of assessments are carried out of non-pharmaceutical health technologies than of pharmaceuticals, 10 countries (45%) complete less than 30 assessments per year for non-pharmaceutical health technologies compared to 4 countries (14%) for pharmaceuticals. For pharmaceuticals, a smaller number of countries assess inpatient than outpatient technologies (22 (76%) and 29 (100%) countries, respectively). However, for non-pharmaceutical health technology assessment most countries (20 out of 22 (91%)) do not differentiate between settings.